Skip to main content

Wetherby Asset Management Inc

SEC CIK
0001279627
Latest filing
Nov 14, 2025

FDMT holding history

4D Molecular Therapeutics, Inc. in every 13F filed by Wetherby Asset Management Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FDMT overviewAll 13F holders of FDMTFull Q3 2025 holdings

Shares (Q2 2022)
0
Sold out in Q2 2022
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q1 2022
Holdings of FDMT by Wetherby Asset Management Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20220$00.0%−15,839−100.0%Sold outHolders
Q1 202215,839$239.0K<0.1%+15,839NewHolders